[1] 中华医学会肝病学分会,中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555. [2] 李 杰,陈 杰,庄 辉.丙型肝炎的流行病学[J] .实用肝脏病杂志,2012,15(5):379-381. [3] Sulkowski M S,Cooper C,Hunyady B,et al. Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C[J]. Nat Clin Pract Gastroenterol Hepatol,2011,8(4): 212-223. [4] Fried M W. Side effects of therapy for hepatitis C and their management [J]. Hepatology,2002, 36(5suppl1):S237-S244.
PDF(802 KB)
